Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. It offers Bloxiverz, Vazculep, and Akovaz. The company was founded on December 1, 2015 and is headquartered in Dublin, Ireland.
SHORT INTEREST
6.53M 07/31/19
P/E Current
-0.85
P/E Ratio (with extraordinary items)
-0.80
Average Recommendation: BUY
Average Target Price: 4.50
SHORT INTEREST
6.53M 07/31/19
P/E Current
-0.85
P/E Ratio (with extraordinary items)
-0.80
Average Recommendation: BUY
Average Target Price: 4.50
⭐⭐⭐ Sign Up for Free ⭐⭐⭐
1) Download our App on Google Play! dexwirenews.com/APP
2) Text Message Notifications: dexwirenews.com/SMS
3) Telegram: t.me/DEXWireNews
4) Follow @DEXWireNews on Social Media
1) Download our App on Google Play! dexwirenews.com/APP
2) Text Message Notifications: dexwirenews.com/SMS
3) Telegram: t.me/DEXWireNews
4) Follow @DEXWireNews on Social Media